1,721,188 research outputs found
sj-pdf-4-msj-10.1177_1352458518814117 – Supplemental material for Slowly expanding/evolving lesions as a magnetic resonance imaging marker of chronic active multiple sclerosis lesions
No full textSupplemental material, sj-pdf-4-msj-10.1177_1352458518814117 for Slowly expanding/evolving lesions as a magnetic resonance imaging marker of chronic active multiple sclerosis lesions by Colm Elliott, Jerry S Wolinsky, Stephen L Hauser, Ludwig Kappos, Frederik Barkhof, Corrado Bernasconi, Wei Wei, Shibeshih Belachew and Douglas L Arnold in Multiple Sclerosis Journal</p
sj-pdf-5-msj-10.1177_1352458518814117 – Supplemental material for Slowly expanding/evolving lesions as a magnetic resonance imaging marker of chronic active multiple sclerosis lesions
No full textSupplemental material, sj-pdf-5-msj-10.1177_1352458518814117 for Slowly expanding/evolving lesions as a magnetic resonance imaging marker of chronic active multiple sclerosis lesions by Colm Elliott, Jerry S Wolinsky, Stephen L Hauser, Ludwig Kappos, Frederik Barkhof, Corrado Bernasconi, Wei Wei, Shibeshih Belachew and Douglas L Arnold in Multiple Sclerosis Journal</p
sj-pdf-3-msj-10.1177_1352458518814117 – Supplemental material for Slowly expanding/evolving lesions as a magnetic resonance imaging marker of chronic active multiple sclerosis lesions
No full textSupplemental material, sj-pdf-3-msj-10.1177_1352458518814117 for Slowly expanding/evolving lesions as a magnetic resonance imaging marker of chronic active multiple sclerosis lesions by Colm Elliott, Jerry S Wolinsky, Stephen L Hauser, Ludwig Kappos, Frederik Barkhof, Corrado Bernasconi, Wei Wei, Shibeshih Belachew and Douglas L Arnold in Multiple Sclerosis Journal</p
sj-pdf-2-msj-10.1177_1352458518814117 – Supplemental material for Slowly expanding/evolving lesions as a magnetic resonance imaging marker of chronic active multiple sclerosis lesions
No full textSupplemental material, sj-pdf-2-msj-10.1177_1352458518814117 for Slowly expanding/evolving lesions as a magnetic resonance imaging marker of chronic active multiple sclerosis lesions by Colm Elliott, Jerry S Wolinsky, Stephen L Hauser, Ludwig Kappos, Frederik Barkhof, Corrado Bernasconi, Wei Wei, Shibeshih Belachew and Douglas L Arnold in Multiple Sclerosis Journal</p
sj-docx-1-msj-10.1177_13524585231195346 – Supplemental material for Efficacy and safety of four-year ofatumumab treatment in relapsing multiple sclerosis: The ALITHIOS open-label extension
No full textSupplemental material, sj-docx-1-msj-10.1177_13524585231195346 for Efficacy and safety of four-year ofatumumab treatment in relapsing multiple sclerosis: The ALITHIOS open-label extension by Stephen L Hauser, Ronald Zielman, Ayan Das Gupta, Jing Xi, Dee Stoneman, Goeril Karlsson, Derrick Robertson, Jeffrey A Cohen and Ludwig Kappos in Multiple Sclerosis Journal</p
sj-docx-1-msj-10.1177_1352458518814117 – Supplemental material for Slowly expanding/evolving lesions as a magnetic resonance imaging marker of chronic active multiple sclerosis lesions
No full textSupplemental material, sj-docx-1-msj-10.1177_1352458518814117 for Slowly expanding/evolving lesions as a magnetic resonance imaging marker of chronic active multiple sclerosis lesions by Colm Elliott, Jerry S Wolinsky, Stephen L Hauser, Ludwig Kappos, Frederik Barkhof, Corrado Bernasconi, Wei Wei, Shibeshih Belachew and Douglas L Arnold in Multiple Sclerosis Journal</p
MSJ793527_supplementary_material – Supplemental material for Toward a low-cost, in-home, telemedicine-enabled assessment of disability in multiple sclerosis
No full textSupplemental material, MSJ793527_supplementary_material for Toward a low-cost, in-home, telemedicine-enabled assessment of disability in multiple sclerosis by Riley Bove, Carolyn Bevan, Elizabeth Crabtree, Chao Zhao, Refujia Gomez, Priya Garcha, John Morrissey, Jason Dierkhising, Ari J Green, Stephen L Hauser, Bruce AC Cree, Mitchell T Wallin and Jeffrey M Gelfand in Multiple Sclerosis Journal</p
sj-docx-1-msj-10.1177_13524585221078825 – Supplemental material for Efficacy and safety of ofatumumab in recently diagnosed, treatment-naive patients with multiple sclerosis: Results from ASCLEPIOS I and II
No full textSupplemental material, sj-docx-1-msj-10.1177_13524585221078825 for Efficacy and safety of ofatumumab in recently diagnosed, treatment-naive patients with multiple sclerosis: Results from ASCLEPIOS I and II by Jutta Gärtner, Stephen L Hauser, Amit Bar-Or, Xavier Montalban, Jeffrey A Cohen, Anne H Cross, Kumaran Deiva, Habib Ganjgahi, Dieter A Häring, Bingbing Li, Ratnakar Pingili, Krishnan Ramanathan, Wendy Su, Roman Willi, Bernd Kieseier and Ludwig Kappos in Multiple Sclerosis Journal</p
Going Beyond Counting First Authors in Author Co-citation Analysis
Full text linkThe present study examines one of the fundamental aspects of author co-citation analysis (ACA) - the way co-citation
counts are defined. Co-citation counting provides the data on which all subsequent statistical analyses and mappings
are based, and we compare ACA results based on two different types of co-citation counting - the traditional type that
only counts the first one among a cited work's authors on the one hand and a non-traditional type that takes into
account the first 5 authors of a cited work on the other hand. Results indicate that the picture produced through this non-traditional author co-citation counting contains more coherent author groups and is therefore considerably clearer. However, this picture represents fewer specialties in the research field being studied than that produced through the traditional first-author co-citation counting when the same number of top-ranked authors is selected and analyzed. Reasons for these effects are discussed
- …
